CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Anisomycin can inhibit the proliferation of chronic myeloid leukemia (CML) CD34 stem cells and induce apoptosis, and the combination of imatinib or dasatinib can significantly improve their efficacy.